MEMOTEXT patient engagement platform
Implement a digital COVID-19 assessment solution for your organization that is evidence-based, secure and easy to use. RapidResponse will handle assessments, follow-ups, resource navigation, location entry, and monitoring needed to keep your organization safe.
We’re a digital patient engagement platform that uses health data and analytics to optimize digital communications and deliver ROI to patients and healthcare stakeholders.
Let us show you how you can grow your very own digital patient engagement program!
our Mission
We use claims data, wearables, electronic medical records, and patient inputs to identify risk and personalize communications.
Through AI voice assistants, SMS messaging, iOS/Android and even plain old telephone calls (IVR), we use data to drive patient behavior.
MEMOTEXT has been shown to improve adherence to treatment, care-coordination and outcomes.
Our Methodology
Evidence guides how we help you build, sequence and deliver personalized digital patient engagement interventions.
Empathy drives our understanding of stigma, denial, fatigue, hope associated with health engagement.
Experience means time and knowledge related to patient privacy, cyber security, regulatory compliance, HIPAA, PIPEDA, GDPR.
With the Centre for Addiction and Mental Health (CAMH) we’ve co-commercialized a digital therapeutic asset to support complex behavioral health. A patient engagement app and clinician portal with a regulatory (FDA) pathway, A4i improves support, reduces isolation and provides relapse/readmission insights.
Connected to the Nurse in the Cloud with homecare partners, SE Health. The Ring of Support provides personalized support through smart assistant technology (Amazon Alexa) to prolong independence for seniors and provide peace of mind for caregivers.
A T2 diabetes chatbot for population health management that encourages members to pursue healthcare goals. Paired with custom messaging and adherence notifications, users are able to work towards better health outcomes.
By: Dr. Sean Kidd and Amos Adler A4i Digital Therapeutic co-founders Amos Adler and Dr....
By: Gillian Drukmaler | Business Development Manager Over the past year and a half, you...
By: Amos Adler M.Sc. LETS FACE IT, ITS BEEN A CHALLENGING YEAR March 11, was...
COVID-19 has changed life as we knew it, and likely for the foreseeable future. For companies...
The start of a school year normally feels like the start of something exciting and...
In a recent study published in the Journal of Psychopharmacology, we were able to share the results of our SOFIA...
By Gillian Drukmaler | Intern If you are reading this, it’s likely that you know at least one family member, friend,...
By Amos Adler | Co-Founder, CEO So here we are, its 2020, we all have...
We’re a small but mighty team. We’ve crunched data, created questionnaires, integrated, tested and drank lots of coffee in the process. Get to know the people that make up MEMOTEXT!
US Office
4416 East West Highway
4th Floor
Bethesda, MD. 20814
Canadian Office
7 Belmont St
Toronto, ON. M5R 1P9
Phone : 1.877.MEMOTXT (1.877.636.6898)
Email : memo@memotext.com